MarginsXMarginsX
Home › Markets › Health Care › TELA

TELA Bio Inc. (TELA)

TELA trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.7616
-7.13% on the day
Market cap
$34.4M
Nano cap
Revenue · 2025
$80.3M
+15.8% on 2024
Net income · 2025
-$38.8M
-48.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1561921/000110465926034507/0001104659-26-034507-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerTELA on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2019
SEC CIK0001561921
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$80.3M
Net income-$38.8M
Operating income-$33.8M
Net margin-48.4%
Operating margin-42.0%
Revenue growth+15.8%
Cash$50.8M
Total assets$81.4M
P/E (computed)Net income was not positive
P/S (computed)0.4×

Warning signs

Cash runway
8.0 months
$22.7M cash at September 30, 2026
Share count, 1 year
+12.0%
2025-11-03 to 2026-11-05 · +84.5% over 3 years
Going-concern doubt
Yes
10-Q filed November 10, 2026
Insider net buying, 12 months
$4.2M
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Notes to Unaudited Interim Consolidated Financial Statements (Continued) These conditions and events raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these consolidated financial statements are issued."
10-Q 2026-11-10
Cash and burn$22.7M cash; operating cash flow -$8.5M a quarter.Report 2026-09-30
Shares outstanding45,188,230 (2026-11-05); 40,341,535 a year earlier; 24,488,803 three years earlier.Cover page 2026-11-05
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-11-10
Exchange deficiency notices, 12 months2 (8-K item 3.01)8-K 2026-09-18
AuditorKPMG LLP, Philadelphia, Pennsylvania, United StatesPCAOB Form AP 2026-04-21
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $4.2M, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$19.0M-$9.3M-$8.7M$22.7M$56.3M$78.2M10-Q 2026-11-10
Q2 2026
2026-06-30
$19.3M-$11.3M-$9.4M$30.4M$56.1M$79.9M10-Q 2026-08-11
Q1 2026
2026-03-31
$19.1M-$12.3M-$11.2M$39.5M$55.9M$80.8M10-Q 2026-05-13
Q4 2025
2025-12-31
$20.9M-$9.0M-$4.9M$50.8M$55.7M$80.3M10-K 2026-03-25
Q3 2025
2025-09-30
$20.7M-$8.6M-$5.7M$29.7M$41.5M$77.1M10-Q 2026-11-10
Q2 2025
2025-06-30
$20.2M-$9.9M-$7.9M$35.0M$41.4M$75.3M10-Q 2026-08-11
Q1 2025
2025-03-31
$18.5M-$11.3M-$9.7M$42.8M$41.3M$71.2M10-Q 2026-05-13
Q4 2024
2024-12-31
$17.6M-$9.2M-$7.5M$52.7M$41.1M$69.3M10-K 2026-03-25

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-32026-11-10
Latest annual report10-K2026-03-25
Latest quarterly / interim10-Q2026-11-10
Latest current report
FORM 8-K
8-K2026-11-10
Latest proxyDEF 14A2026-09-14

Source: SEC EDGAR submissions feed, 551 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week0.0%
1 month-23.0%
3 months+20.9%
Year to date-30.5%
1 year-26.1%
From 52-week high-41.8%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
NEPHNephros Inc.$3.00-1.64%$32.6M
SRTSSensus Healthcare Inc.$2.34+0.65%$38.5M
XTNTXtant Medical Holdings Inc.$0.2098-22.78%$29.4M
MDAISpectral AI Inc.$1.31+0.77%$42.2M
NSPRInspireMD Inc.$0.6000-6.85%$28.1M
MBOTMicrobot Medical Inc.$0.6444-34.16%$43.3M
ADGMAdagio Medical Holdings Inc$1.61-16.58%$44.2M
PLRZPolyrizon Ltd.$10.70-2.37%$26.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier